Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

Check out our portfolio of awards below.

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Stanford University Dr. Gerald R. Crabtree Basic Biology IV Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch $1,392,150
Stanford University Dr. Roel Nusse Basic Biology IV Asymmetric stem cell division oriented by a local self-renewing signal $1,038,600
Buck Institute for Age Research Deepak A Lamba Basic Biology IV 3D Modeling of Retina using Polymer Scaffolds for Understanding Disease Pathogenesis $1,212,553
University of California, San Francisco Dr. Jeremy Reiter Basic Biology IV Modeling disease in human embryonic stem cells using new genetic tools $1,387,800
University of California, San Francisco Barbara Panning Basic Biology IV Investigation of the role of O-GlcNAcylation in SOX2 function during reprogramming $1,260,037
University of California, Davis Dr. Deborah K Lieu Basic Biology IV Induction of Pluripotent Stem Cell-Derived Pacemaking Cells $1,333,689
Stanford University Dr. Howard Y. Chang Basic Biology IV Long noncoding RNAs for pluripotency and cell fate commitment $1,386,627
University of California, San Diego Miles F Wilkinson Basic Biology IV Role of the NMD RNA Decay Pathway in Maintaining the Stem-Like State $1,360,450
Sanford Burnham Prebys Medical Discovery Institute Dr. Huei-sheng Vincent Chen Basic Biology IV Studying Arrhythmogenic Right Ventricular Dysplasia with patient-specific iPS cells $1,579,250
University of California, San Diego Ananda Goldrath Basic Biology IV Mechanisms to protect hESC-derived cells from allogenic immune rejection $1,160,997
City of Hope, Beckman Research Institute Dr. Yanhong Shi Ph.D. Basic Biology IV Modeling Alexander disease using patient-specific induced pluripotent stem cells $1,366,656
Cedars-Sinai Medical Center Eduardo Marbán Basic Biology IV Mechanism of heart regeneration by cardiosphere-derived cells $1,367,604
University of California, San Diego Maike Sander Basic Biology IV Deciphering transcriptional control of pancreatic beta-cell maturation in vitro $1,258,560
University of California, San Diego Dr. David Traver Basic Biology IV DECIPHERING THE INSTRUCTIONS FOR VERTEBRATE HSC SPECIFICATION AND AMPLIFICATION. $1,363,698
University of California, Los Angeles Dr. Owen N Witte M.D. Basic Biology IV Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells $1,254,960
Stanford University Ben A Barres Basic Biology IV Phenotyping Human Astrocytes in Health and Disease $0
University of California, Berkeley Dr. Robert Tjian Basic Biology IV Transcriptional regulation of pluripotency in human embryonic stem cells $1,220,968
University of California, Los Angeles Dr. Kathrin Plath Dr. Basic Biology IV Understanding the status of the X chromosomes in human ESCs and preimplantation embryos $1,382,400
Gladstone Institutes, J. David Dr. Steve M. Finkbeiner Basic Biology IV Common molecular mechanisms in neurodegenerative diseases using patient based iPSC neurons $1,395,184
Stanford University Alexander Robert Dunn Basic Biology IV Role of mechanical signaling in stem cell self-renewal and differentiation $1,062,998
Stanford University Dr. Anne Brunet Basic Biology IV Energy metabolism and aging pathways in human stem cell reprogramming and differentiation $1,414,044
University of California, San Francisco Dr. Miguel Ramalho-Santos Basic Biology IV Genetic dissection of human cellular reprogramming to pluripotency $1,184,883
Gladstone Institutes, J. David Sheng Ding PhD Basic Biology IV A new paradigm of lineage-specific reprogramming $1,568,395
Stanford University Michael Cleary Basic Biology IV Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells $1,244,455
Stanford University Michelle Monje Basic Biology IV Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain $1,264,248
University of California, San Diego Gene Wei-Ming Yeo Basic Biology IV Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration $1,260,360
Cedars-Sinai Medical Center Professor Clive Niels Svendsen iPSC Consortia Award The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development $300,000
Stanford University Dr. Joseph C. Wu Disease Team Therapy Development – Research Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $19,060,330
Capricor, Inc Dr. Rachel Ruckdeschel Smith Disease Team Therapy Development – Research Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction $14,405,857
University of California, Los Angeles Dr. Antoni Ribas MD/PhD Disease Team Therapy Development – Research Genetic Re-programming of Stem Cells to Fight Cancer $14,144,221
University of California, Los Angeles Dr. Stanley Nelson Disease Team Therapy Development – Research Combination Therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $0
University of California, Irvine Dr. Henry John Klassen Disease Team Therapy Development – Research Retinal progenitor cells for treatment of retinitis pigmentosa $17,144,825
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Development – Research Progenitor Cells Secreting GDNF for the Treatment of ALS $16,168,464
StemCells, Inc. Dr. Alexandra Capela Disease Team Therapy Development – Research Restoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy $8,901,641
Stanford University Dr. Judith A Shizuru Disease Team Therapy Development – Research A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $18,990,683
University of California, Davis Dr. John Laird Disease Team Therapy Development – Research Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia $3,728,384
University of California, Davis Dr. Vicki Wheelock Disease Team Therapy Development – Research MSC engineered to produce BDNF for the treatment of Huntington’s disease $8,924,235
StemCells, Inc. Dr. Nobuko Uchida Disease Team Therapy Development – Research Neural stem cell transplantation for chronic cervical spinal cord injury $0
University of California, Davis Nancy E. Lane Disease Team Therapy Development – Research Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells $18,227,898
Salk Institute for Biological Studies Dr. David R Schubert Early Translational III Stem cell based small molecule therapy for Alzheimer’s disease $1,673,757
City of Hope, Beckman Research Institute Dr. Stephen J Forman Early Translational III Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells $5,215,447
Gladstone Institutes, J. David Dr. Deepak Srivastava Early Translational III Direct Cardiac Reprogramming for Heart Regeneration $5,795,871
University of California, San Diego Dr. Lawrence S. B. Goldstein Early Translational III Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells $1,774,420
University of California, San Diego Dr. Yang Xu Early Translational III Human ES cell based therapy of heart failure without allogenic immune rejection $1,857,600
Stanford University Dr. Joseph C. Wu Early Translational III Heart Repair with Human Tissue Engineered Myocardium $4,395,080
University of California, San Francisco Mort Cowan Early Translational III Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID $3,862,367
Stanford University Professor Helen M. Blau PhD Early Translational III Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,283
University of Southern California Dr. Toshio Miki Early Translational III Generation of hepatic cell from placental stem cell for congenital metabolic disorders $1,750,375
Children’s Hospital of Orange County Dr. Philip H Schwartz Early Translational III Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease $4,266,015
University of California, San Francisco Dr. Holger F Willenbring Early Translational III Generation of safe and therapeutically effective human induced hepatocyte-like cells $1,544,170
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 … 30

How to Apply

Learn More

Explore CIRM-Funded Clinical Trials

Learn More

Managing Your Grant

Learn More

See our Active Awards Portfolio

Learn More